Perrigo Says Rx Generic Pursuits Will Strengthen OTC Private Label Business
This article was originally published in The Tan Sheet
Executive Summary
Perrigo's move into prescription generics will further enhance its market-leading position in private label over-the-counter and Rx-to-OTC switch drugs, the firm claims